Dr. Christian Baum

Stuff I Worry About: High-Risk Squamous Cell Carcinoma and High-Risk Patients

Dr. Baum presented information about tumor- and patient-specific risk factors for cutaneous squamous cell carcinoma (cSCC). First, Dr. Baum noted that the cSCC incidence in the US is increasing, with an estimated 180,000–520,000 new cases annually and a metastatic rate of 2–5%. Patients with bulky nodal disease have higher recurrence rates and lower overall survival…

In-Transit Melanoma Metastases

Dr. Baum described melanoma in-transit metastases (ITMs) and presented an overview of current treatments. Melanoma ITMs are lesions that develop between the primary tumor site and the draining nodal basin via lymphatic seeding, separate from spreading in the blood. ITMs occur in 5–10% of patients with melanoma and typically develop within 13–18 months. Fifty percent…